Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 533

1.

Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain.

Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K, Wang W, Pandya A, Chen YY, Mikolich JR, Boland S, Arai AE, Bandettini WP, Shanbhag SM, Patel AR, Narang A, Farzaneh-Far A, Romer B, Heitner JF, Ho JY, Singh J, Shenoy C, Hughes A, Leung SW, Marji M, Gonzalez JA, Mehta S, Shah DJ, Debs D, Raman SV, Guha A, Ferrari VA, Schulz-Menger J, Hachamovitch R, Stuber M, Simonetti OP.

J Am Coll Cardiol. 2019 Oct 8;74(14):1741-1755. doi: 10.1016/j.jacc.2019.07.074.

2.

Spatio-angular filter (SAF) imaging device for deep interrogation of scattering media.

Pandya A, Schelkanova I, Douplik A.

Biomed Opt Express. 2019 Aug 20;10(9):4656-4663. doi: 10.1364/BOE.10.004656. eCollection 2019 Sep 1.

3.

Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment.

Kuehne F, Jahn B, Conrads-Frank A, Bundo M, Arvandi M, Endel F, Popper N, Endel G, Urach C, Gyimesi M, Murray EJ, Danaei G, Gaziano TA, Pandya A, Siebert U.

J Comp Eff Res. 2019 Sep;8(12):1013-1025. doi: 10.2217/cer-2018-0103. Epub 2019 Sep 12.

PMID:
31512926
4.

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.

Pandya AD, Jäger E, Bagheri Fam S, Höcherl A, Jäger A, Sincari V, Nyström B, Štěpánek P, Skotland T, Sandvig K, Hrubý M, Mælandsmo GM.

Int J Nanomedicine. 2019 Aug 6;14:6269-6285. doi: 10.2147/IJN.S208938. eCollection 2019.

5.

Development and Evaluation of an Autonomous Camera Control Algorithm on the da Vinci Surgical System.

Eslamian S, Reisner LA, Pandya AK.

Int J Med Robot. 2019 Sep 6:e2036. doi: 10.1002/rcs.2036. [Epub ahead of print]

PMID:
31490615
6.

Efficient Alpha Radiation Detector using Low Temperature Hydrothermally Grown ZnO:Ga Nanorod Scintillator.

Sahani RM, Kumari C, Pandya A, Dixit A.

Sci Rep. 2019 Aug 6;9(1):11354. doi: 10.1038/s41598-019-47732-1.

7.

Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.

Gaziano TA, Pandya A, Sy S, Jardim TV, Ogden JM, Rodgers A, Weinstein MC.

Am Heart J. 2019 Aug;214:77-87. doi: 10.1016/j.ahj.2019.04.020. Epub 2019 May 7.

PMID:
31174054
8.

Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel.

Shen J, Oza AM, Del Castillo I, Duzkale H, Matsunaga T, Pandya A, Kang HP, Mar-Heyming R, Guha S, Moyer K, Lo C, Kenna M, Alexander JJ, Zhang Y, Hirsch Y, Luo M, Cao Y, Wai Choy K, Cheng YF, Avraham KB, Hu X, Garrido G, Moreno-Pelayo MA, Greinwald J, Zhang K, Zeng Y, Brownstein Z, Basel-Salmon L, Davidov B, Frydman M, Weiden T, Nagan N, Willis A, Hemphill SE, Grant AR, Siegert RK, DiStefano MT, Amr SS, Rehm HL, Abou Tayoun AN; ClinGen Hearing Loss Working Group.

Genet Med. 2019 Jun 4. doi: 10.1038/s41436-019-0535-9. [Epub ahead of print]

PMID:
31160754
9.

Cancer Risk in Klippel-Trenaunay Syndrome.

Blatt J, Finger M, Price V, Crary SE, Pandya A, Adams DM.

Lymphat Res Biol. 2019 May 2. doi: 10.1089/lrb.2018.0049. [Epub ahead of print]

PMID:
31045469
10.

Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.

Rymer K, Shiang R, Hsiung A, Pandya A, Bigdeli T, Webb BT, Rhodes J.

Mol Genet Genomic Med. 2019 Jun;7(6):e656. doi: 10.1002/mgg3.656. Epub 2019 Apr 23.

11.

A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo.

McKesey J, Pandya AG.

J Am Acad Dermatol. 2019 Aug;81(2):646-648. doi: 10.1016/j.jaad.2019.04.032. Epub 2019 Apr 19. No abstract available.

PMID:
31009664
12.

Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting.

van Geel N, Wolkerstorfer A, Ezzedine K, Pandya AG, Bekkenk M, Grine L, Van Belle S, Lommerts JE, Hamzavi I, Harris JE, Eleftheriadou V, Esmat S, Kang HY, Kumarasinghe P, Lan CE, Parsad D, Raboobee N, Flora Xiang L, Suzuki T, Prinsen CA, Taieb A, Picardo M, Speeckaert R; participants of the Rome International VGICC /VIS Workshop.

Pigment Cell Melanoma Res. 2019 Sep;32(5):728-733. doi: 10.1111/pcmr.12784. Epub 2019 May 9.

PMID:
30945409
13.

Disorders of Hypopigmentation

Dina Y, McKesey J, Pandya AG.

J Drugs Dermatol. 2019 Mar 1;18(3):s115-s116.

PMID:
30909355
14.

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds.

Li W, Stevens CM, Pandya AN, Darzynkiewicz Z, Bhattarai P, Tong W, Gonzalez-Juarrero M, North EJ, Zgurskaya HI, Jackson M.

ACS Infect Dis. 2019 Jun 14;5(6):1001-1012. doi: 10.1021/acsinfecdis.9b00048. Epub 2019 Mar 28.

15.

Acute Administration of Desformylflustrabromine Relieves Chemically Induced Pain in CD-1 Mice.

Weggel LA, Pandya AA.

Molecules. 2019 Mar 7;24(5). pii: E944. doi: 10.3390/molecules24050944.

16.

Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs).

Ezzedine K, Ahmed M, Tovar-Garza A, Hajj C, Whitton M, Pandya A, Altalhab S, Seneschal J, Harris J, Taieb C.

J Am Acad Dermatol. 2019 Nov;81(5):1107-1114. doi: 10.1016/j.jaad.2019.02.008. Epub 2019 Feb 11.

PMID:
30763647
17.

Para-Bombay phenotype: A case report from a tertiary care hospital from South Gujarat.

Patel JN, Donta AB, Patel AC, Pandya AN, Kulkarni SS.

Asian J Transfus Sci. 2018 Jul-Dec;12(2):180-182. doi: 10.4103/ajts.AJTS_151_17.

18.

Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.

Pandya A, Asch DA, Volpp KG, Sy S, Troxel AB, Zhu J, Weinstein MC, Rosenthal MB, Gaziano TA.

JAMA Netw Open. 2018 Sep 7;1(5):e182008. doi: 10.1001/jamanetworkopen.2018.2008.

19.

Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection.

Pandya AN, Prathipati PK, Hegde P, Li W, Graham KF, Mandal S, Drescher KM, Destache CJ, Ordway D, Jackson M, North EJ.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02245-18. doi: 10.1128/AAC.02245-18. Print 2019 Mar.

20.

Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft.

Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM.

J Control Release. 2019 Jan 10;293:183-192. doi: 10.1016/j.jconrel.2018.11.029. Epub 2018 Dec 4.

21.

Noncultured epidermal suspension grafting using suction blisters as donor tissue for vitiligo.

Tovar-Garza A, Hinojosa JA, Hynan LS, Pandya AG.

J Am Acad Dermatol. 2019 Apr;80(4):1152-1154. doi: 10.1016/j.jaad.2018.10.041. Epub 2018 Oct 27. No abstract available.

PMID:
30393095
22.
23.

Improving Health Care Value by Considering Cost-effectiveness-Reply.

Pandya A.

JAMA. 2018 Sep 25;320(12):1287-1288. doi: 10.1001/jama.2018.10624. No abstract available.

PMID:
30264111
24.

An Evaluation of the Potential of NMR Spectroscopy and Computational Modelling Methods to Inform Biopharmaceutical Formulations.

Pandya A, Howard MJ, Zloh M, Dalby PA.

Pharmaceutics. 2018 Sep 21;10(4). pii: E165. doi: 10.3390/pharmaceutics10040165. Review.

25.

Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo.

Tovar-Garza A, Hinojosa JA, Hynan LS, Pandya AG.

Br J Dermatol. 2019 Jan;180(1):193-194. doi: 10.1111/bjd.17150. Epub 2018 Oct 10. No abstract available.

PMID:
30188576
26.

A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.

Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D.

Int J Dermatol. 2019 Mar;58(3):263-272. doi: 10.1111/ijd.14189. Epub 2018 Sep 3. Review.

PMID:
30176055
27.

Modelling the cost-effectiveness of pay-for-performance in primary care in the UK.

Pandya A, Doran T, Zhu J, Walker S, Arntson E, Ryan AM.

BMC Med. 2018 Aug 29;16(1):135. doi: 10.1186/s12916-018-1126-3.

28.

Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A3 receptor antagonists: SAR and molecular modeling studies.

Pandya AN, Baraiya AB, Jalani HB, Pandya D, Kaila JC, Kachler S, Salmaso V, Moro S, Klotz KN, Vasu KK.

Medchemcomm. 2018 Mar 13;9(4):676-684. doi: 10.1039/c7md00643h. eCollection 2018 Apr 1.

29.

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections.

Li W, Yazidi A, Pandya AN, Hegde P, Tong W, Calado Nogueira de Moura V, North EJ, Sygusch J, Jackson M.

Front Microbiol. 2018 Jul 10;9:1547. doi: 10.3389/fmicb.2018.01547. eCollection 2018.

30.

International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.

Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K.

Br J Dermatol. 2019 Mar;180(3):574-579. doi: 10.1111/bjd.17013. Epub 2018 Oct 5.

PMID:
30030843
31.

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaam7710. doi: 10.1126/scitranslmed.aam7710.

32.

Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations.

Pandya A, Caoili EM, Jawad-Makki F, Wasnik AP, Shankar PR, Bude R, Haymart MR, Davenport MS.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3496-3502. doi: 10.1210/jc.2018-00792.

PMID:
29982716
33.

The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.

Smith CR, Chiarelli AM, Holloway CM, Mirea L, O'Malley FP, Blackmore KM, Pandya A, Majpruz V, Harris CP, Hendry A, Hey A, Kornecki A, Lougheed G, Maier BA, Marchand P, McCready D, Rand C, Raphael S, Segal-Nadler R, Sehgal N, Muradali D.

Breast. 2018 Oct;41:25-33. doi: 10.1016/j.breast.2018.06.007. Epub 2018 Jun 18.

34.

Risk of Infection and Sepsis in Pediatric Patients with Traumatic Brain Injury Admitted to Hospital Following Major Trauma.

Pandya A, Chaput KH, Schertzer A, Moser D, Guilfoyle J, MacGillivray S, Blackwood J, Joffe AR, Thompson GC.

Sci Rep. 2018 Jun 28;8(1):9798. doi: 10.1038/s41598-018-28189-0.

35.

Dataset on a 173 region awake resting state quantitative cerebral blood volume rat brain atlas and regional changes to cerebral blood volume under isoflurane anesthetization and CO2 challenge.

Gharagouzloo CA, Timms L, Qiao J, Fang Z, Nneji J, Pandya A, Kulkarni P, van de Ven AL, Ferris C, Sridhar S.

Data Brief. 2018 Jan 31;17:393-396. doi: 10.1016/j.dib.2018.01.021. eCollection 2018 Apr.

36.

The effect of melasma on self-esteem: A pilot study.

Jiang J, Akinseye O, Tovar-Garza A, Pandya AG.

Int J Womens Dermatol. 2017 Dec 8;4(1):38-42. doi: 10.1016/j.ijwd.2017.11.003. eCollection 2018 Mar.

37.

Validity of Administrative Databases in Comparison to Medical Charts for Breast Cancer Treatment Data.

Weerasinghe A, Smith CR, Majpruz V, Pandya A, Blackmore KM, Holloway CMB, Segal-Nadlere R, Paroschy Harris C, Hendry A, Hey A, Kornecki A, Lougheed G, Maier BA, Marchand P, McCready D, Rand C, Raphael S, Sehgal N, Chiarelli AM.

J Cancer Epidemiol. 2018 May 14;2018:9218595. doi: 10.1155/2018/9218595. eCollection 2018.

38.

Successful treatment with narrowband ultraviolet B phototherapy of burn-induced leucoderma.

Hinojosa JA, Tovar-Garza A, Pandya AG.

Br J Dermatol. 2018 May;178(5):e327. doi: 10.1111/bjd.16419. No abstract available.

PMID:
29785828
39.

Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.

Prasmickaite L, Tenstad EM, Pettersen S, Jabeen S, Egeland EV, Nord S, Pandya A, Haugen MH, Kristensen VN, Børresen-Dale AL; Oslo Breast Cancer Research Consortium (OSBREAC), Engebråten O, Maelandsmo GM.

Mol Oncol. 2018 Sep;12(9):1540-1558. doi: 10.1002/1878-0261.12319. Epub 2018 Aug 9.

40.

Adding Cost-effectiveness to Define Low-Value Care.

Pandya A.

JAMA. 2018 May 15;319(19):1977-1978. doi: 10.1001/jama.2018.2856. No abstract available.

PMID:
29710341
41.

Oral Tranexamic Acid for the Treatment of Melasma: A Review.

Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M.

Dermatol Surg. 2018 Jun;44(6):814-825. doi: 10.1097/DSS.0000000000001518. Review.

PMID:
29677015
42.

Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.

Fitch RW, Snider BB, Zhou Q, Foxman BM, Pandya AA, Yakel JL, Olson TT, Al-Muhtasib N, Xiao Y, Welch KD, Panter KE.

J Nat Prod. 2018 Apr 27;81(4):1029-1035. doi: 10.1021/acs.jnatprod.8b00062. Epub 2018 Apr 19.

PMID:
29671588
43.

Diversity in dermatology: Roadmap for improvement.

Pritchett EN, Pandya AG, Ferguson NN, Hu S, Ortega-Loayza AG, Lim HW.

J Am Acad Dermatol. 2018 Aug;79(2):337-341. doi: 10.1016/j.jaad.2018.04.003. Epub 2018 Apr 10.

PMID:
29653209
44.

Statins and the Classic Decision Analysis: Treat, Test, or Neither?

Pandya A.

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004688. doi: 10.1161/CIRCOUTCOMES.118.004688. No abstract available.

PMID:
29650718
45.

Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle.

Kansara K, Patel P, Shukla RK, Pandya A, Shanker R, Kumar A, Dhawan A.

Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):79-82. doi: 10.2147/IJN.S124708. eCollection 2018. Erratum in: Int J Nanomedicine. 2018 Jul 19;13:4207-4208.

46.

Curcumin Ag nanoconjugates for improved therapeutic effects in cancer.

Shah D, Savaliya R, Patel P, Kansara K, Pandya A, Dhawan A, Singh S.

Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):75-77. doi: 10.2147/IJN.S124696. eCollection 2018.

47.

Multifunctional Silver-Cellulose Nanocomposite as a Promising Plasmonic Sensing Platform.

Dave H, Bhandari N, Mod B, Shukla R, Pandya A.

J Nanosci Nanotechnol. 2018 Aug 1;18(8):5461-5469. doi: 10.1166/jnn.2018.15407.

PMID:
29458599
48.

Analysis of risk factors associated with unilateral hearing loss in children who initially passed newborn hearing screening.

Appelbaum EN, Howell JB, Chapman D, Pandya A, Dodson KM.

Int J Pediatr Otorhinolaryngol. 2018 Mar;106:100-104. doi: 10.1016/j.ijporl.2018.01.024. Epub 2018 Feb 2.

PMID:
29447880
49.

Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome.

Zarate YA, Smith-Hicks CL, Greene C, Abbott MA, Siu VM, Calhoun ARUL, Pandya A, Li C, Sellars EA, Kaylor J, Bosanko K, Kalsner L, Basinger A, Slavotinek AM, Perry H, Saenz M, Szybowska M, Wilson LC, Kumar A, Brain C, Balasubramanian M, Dubbs H, Ortiz-Gonzalez XR, Zackai E, Stein Q, Powell CM, Schrier Vergano S, Britt A, Sun A, Smith W, Bebin EM, Picker J, Kirby A, Pinz H, Bombei H, Mahida S, Cohen JS, Fatemi A, Vernon HJ, McClellan R, Fleming LR, Knyszek B, Steinraths M, Velasco Gonzalez C, Beck AE, Golden-Grant KL, Egense A, Parikh A, Raimondi C, Angle B, Allen W, Schott S, Algrabli A, Robin NH, Ray JW, Everman DB, Gambello MJ, Chung WK.

Am J Med Genet A. 2018 Apr;176(4):925-935. doi: 10.1002/ajmg.a.38630. Epub 2018 Feb 13.

PMID:
29436146
50.

Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City.

Parikh NS, Chatterjee A, Díaz I, Pandya A, Merkler AE, Gialdini G, Kummer BR, Mir SA, Lerario MP, Fink ME, Navi BB, Kamel H.

Stroke. 2018 Feb;49(2):370-376. doi: 10.1161/STROKEAHA.117.018166. Epub 2018 Jan 17.

Supplemental Content

Loading ...
Support Center